Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression
- PMID: 8707410
- DOI: 10.1002/(SICI)1097-0215(19960729)67:3<365::AID-IJC10>3.0.CO;2-7
Natural resistance against tumors grafted into the brain in association with histocompatibility-class-I-antigen expression
Abstract
The role of MHC-class-I-antigen expression in intracerebral anti-tumor natural resistance was examined using MHC-positive Lym+ and MHC-negative Lym- lymphoma cell lines. Lym+ was sensitive to MHC-class-I-restricted CTL-mediated lysis, while lym- was resistant. Both lines were susceptible to NK-cell-mediated lysis. There was no difference in in vitro growth rate of in vivo intraperitoneal tumorigenicity between them. Inoculation of Lym+ cells into the brain caused upregulation of the intracellular MHC mRNA to the same level as after treatment with interferon-gamma, resulting in an increase in cell-surface MHC expression. Although inoculated Lym- cells also underwent an increase in cytosolic MHC mRNA, the cell-surface MHC expression remained negative. Immunoprecipitation revealed that the terminal glycosylation did not occur normally in Lym-. An in vivo intracerebral tumorigenicity assay, using 2 groups of untreated and NK-cell-depleted syngeneic mice, showed that Lym+ was less tumorigenic than Lym-. In T-cell-depleted mice, however, no difference was detected between them. In addition, when Lym+ and Lym- cells were inoculated into the brain of allogeneic or syngeneic preimmunized mice (immunized with tumor cells), Lym+ was rejected, while Lym- was accepted. When allogeneic mice had received treatment for T-cell depletion before intracerebral inoculation, no rejection was observed in Lym+. On the other hand, Lym- cells, when injected i.p. into NK-depleted mice, had greater killing activity than Lym+ cells, while in T-cell-depleted mice Lym- was less tumorigenic than Lym+. These results suggest that MHC-positive tumor cells grafted into the brain may be rejected by CTL in an MHC-dependent manner, whereas MHC-negative tumor cells can escape from T-cell-mediated immunosurveillance and grow progressively in the brain, due to absence of intracerebral natural resistance mediated by NK cells.
Similar articles
-
Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.J Neurosurg. 2003 Mar;98(3):599-606. doi: 10.3171/jns.2003.98.3.0599. J Neurosurg. 2003. PMID: 12650434
-
[Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].No Shinkei Geka. 1989 Aug;17(8):717-23. No Shinkei Geka. 1989. PMID: 2586713 Japanese.
-
Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.Eur J Immunol. 1995 May;25(5):1286-91. doi: 10.1002/eji.1830250523. Eur J Immunol. 1995. PMID: 7774631
-
Analysis of HLA expression in human tumor tissues.Cancer Immunol Immunother. 2003 Jan;52(1):1-9. doi: 10.1007/s00262-002-0332-0. Epub 2002 Dec 10. Cancer Immunol Immunother. 2003. PMID: 12536234 Free PMC article. Review.
-
The relationship between MHC antigen expression and metastasis.Adv Cancer Res. 1989;53:89-115. doi: 10.1016/s0065-230x(08)60280-8. Adv Cancer Res. 1989. PMID: 2678949 Review.
Cited by
-
Inflammatory Cell Death, PANoptosis, Mediated by Cytokines in Diverse Cancer Lineages Inhibits Tumor Growth.Immunohorizons. 2021 Jul 21;5(7):568-580. doi: 10.4049/immunohorizons.2100059. Immunohorizons. 2021. PMID: 34290111 Free PMC article.
-
Mouse models of primary central nervous system lymphomas: tools for basing funding and therapeutic strategies.J Neurooncol. 2015 Jan;121(1):9-18. doi: 10.1007/s11060-014-1624-x. Epub 2014 Oct 10. J Neurooncol. 2015. PMID: 25300908 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials